Cost Of Overweight Research Articles

Burden and cost of overweight and obesity in south India public health system

• The Prevalence of Obesity and over weight in Andhra Pradesh is 36.04 per cent. • Dr NTRVST spend US$ 55,200,030 due to Overweight related disease every year. • Obesity/overweight attributable hospitalisations costs were higher among men. • Cardiovascular disease cost US$ 9.82 million due to overweight/obesity in Andhra Pradesh.

Assessing the lifetime costs of overweight

Assessing the lifetime costs of overweight

The Costs of Overweight and Obesity: a Systematic Review

The aim of this paper was to conduct a systematic review of cost-of-illness studies for overweight and adiposity in Germany. We conducted a PubMed search to identify relevant studies. To increase comparability, all cost data were inflated to 2014 prices. For bottom-up studies, we additionally calculated relative cost-differences between normal weight and overweight, as well as adiposity. These relative differences were pooled using meta-analytical techniques and extrapolated to the German population. We identified 15 bottom-up studies, 6 top-down studies and 2 Markov simulations. On average, top-down studies reported direct costs of 7.9 billion Euros and indirect costs of 3.6 billion Euros. Due to between-study heterogeneity, we were not able to pool absolute costs reported in bottom-up studies. The pooled relative cost-differences for studies conducted with adult persons were +22% for the difference between normal weight and overweight and +53% for the difference between normal weight and adiposity. The corresponding effect sizes were 0.07 (- 0.05; 0.19) and 0.15 (0.02; 0.28), respectively. In studies conducted with children and adolescents, relative cost-differences were considerably smaller with corresponding effect sizes being close to zero. Extrapolation of relative pooled cost-differences from bottom-up studies to the German total population yielded direct and indirect excess costs of 22.2 billion Euros for overweight and 23.0 billion Euros for adiposity. We found substantial heterogeneity of cost findings between studies for top-down and bottom-up studies as well, which points to substantial uncertainty and strongly hampers clear statements about the costs of overweight and adiposity. Our findings imply that costs are underestimated by top-down studies, whereas overestimated by our extrapolation. The true costs presumably lie between the findings of both approaches.

The costs of overweight

The costs of overweight

Economic costs of both overweight and obesity among Chinese urban and rural residents, in 2010

Using the latest available data to estimate the direct economic burden of overweight and obesity in China. 'Cost-of-illness' approach was used to calculate the costs of five major non-communicable diseases(NCDs)which were associated with overweight and obesity. National data from the 2010 Chinese Behavioral Risk Factors Surveillance Survey and the 2008 National Health Service Survey were used to compute the Population Attributable Risks(PARs) of overweight and obesity for each major NCDs. Costs specific to overweight and obesity were obtained by multiplying costs of each disease by the PARs for each NCD. In 2010, overweight and obesity were imposing a substantial economic burden on China, responsible for 42.9% of the medical and non-medical yearly costs of the major NCDs in China, with the amount as 90.768 billion RMB. The economic costs of overweight and obesity increased over the years, accounting for 4.5% of the national health expenditure. The high economic burden of overweight and obesity implied the need to develop and implement policies that addressing the behavior-related risk factors and the obese-genic environment, in order to curb the NCDs epidemic in China.

Health care costs of overweight and obesity for Pacific and Maori populations in New Zealand

Health care costs of overweight and obesity for Pacific and Maori populations in New Zealand

The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study

BackgroundObesity is a major global epidemic and a burden to society and health systems. It is well known risk factor for a number of chronic medical conditions with high morbidity and mortality. This study aimed to provide an estimate of the direct costs associated to outpatient and inpatient care of overweight and obesity related diseases in the perspective of the Brazilian Health System (SUS).MethodsPopulation attributable risk (PAR) was calculated for selected diseases related to overweight and obesity and with the following parameters: Relative risk (RR) ≥ 1.20 or RR ≥1.10 and < 1.20, but important problem of public health due its high prevalence. After a broad search in the literature, two meta-analysis were selected to provide RR for PAR calculation. The prevalence rates of overweight and obesity in Brazilians with ≥18 years were obtained from large national survey. The national health database (DATASUS) was used to estimate the annual cost of the Brazilian Unified Health System (SUS) with the diseases included in the analysis. The extracted values were stratified by sex, type of service (inpatient or outpatient care) and year. Data were collected from 2008 to 2010 and the results reflect the average of 3 years. Brazilian costs were converted into US dollars during the analysis using a purchasing power parity basis (2010).ResultsThe estimated total costs in one year with all diseases related to overweight and obesity are US$ 2,1 billion; US$ 1,4 billion (68.4% of total costs) due to hospitalizations and US$ 679 million due to ambulatory procedures. Approximately 10% of these cost is attributable to overweight and obesity.ConclusionThe results confirm that overweight and obesity carry a great economic burden for Brazilian health system and for the society. The knowledge of these costs will be useful for future economic analysis of preventive and treatment interventions.

Getting from Fat to Fit: The Role of Policy in the Obesity Disaster

Increasing health and economic costs of overweight and obesity underscore the urgency of finding effective means of addressing the problem. There is broad support within the public health community for approaches that are holistic in nature, taking into account a host of factors that make up the food environment and ultimately influence individual behaviours. Policies with the power to support substantial and even radical changes in the food environment will require a high degree of political will, a systems approach and global co-operation. Small steps are unlikely to produce adequate results. Change of this magnitude will require newly developed and effectively deployed leadership capacities, particularly within our senior public health workforce.

The burden of hospitalization due to overweight and obesity in Brazil

This article estimates the burden of hospitalization associated with overweight and obesity in Brazil. The analysis of all hospitalizations for men and women from 20 to 60 years of age was based on the National Healthcare Expenditure Database (SIH-SUS), covering more than 70% of all hospital admissions. Data were for the year 2001. Attributable fraction of hospitalizations associated with diseases related to obesity and overweight was based on the combined risks of United States and European cohorts. The population-attributable fraction for each disease studied was multiplied by values reimbursed to the hospitals and summed to obtain total direct costs. Overall costs of overweight and obesity represent 3.02% of total hospitalization costs for men and 5.83% for women, corresponding to 6.8 and 9.3% of all hospitalization (excluding pregnancy). Diseases associated with overweight and obesity had a significant impact on hospitalizations and economic costs in Brazil, and overall percentages were similar to those from developed countries. Since the nutritional transition is still under way in Brazil, overweight had a higher impact than obesity on disease prevalence and costs.